The honest truth about hair-loss DNA testing is that for androgenetic alopecia, family history is already 80% of the answer. If your father went bald and your maternal grandfather went bald, your odds are not a mystery. Nimbus sells a DNA test alongside a telehealth bundle. After five weeks of testing, reporting, and a real clinician appointment, my verdict is a qualified yes, mostly because of how the conversation gets structured.
What the Nimbus Hair DNA Test is
It is a cheek-swab DNA test analyzing 13 genes and 48 variants associated with androgenetic alopecia. The panel covers DHT pathway genes (AR, SRD5A1, SRD5A2 and friends), hair density and follicle-cycle variants, and treatment-response markers that estimate likely response to finasteride and minoxidil. Turnaround is 7 to 10 business days from when the lab receives the sample. The package includes a free telehealth follow-up with a Nimbus-affiliated clinician who reviews the report with you and optionally writes a prescription for a custom-compounded topical that combines finasteride, minoxidil, and other agents based on your genetic profile and clinical picture. Pricing is around $149 for the test bundle.
It is not a comprehensive scalp workup, not a diagnosis of alopecia areata or telogen effluvium, and not a substitute for a dermatologist if your hair loss is patchy, sudden, or post-illness.
Who it’s for
Readers in their 20s or 30s noticing early thinning at the temples or crown, with or without family history, who want a structured entry point into the treatment conversation. People considering finasteride or oral minoxidil who want a genetic read on likely response before committing to a multi-year regimen. Anyone whose primary-care doctor waved them off and who wants a clinician who actually specializes in hair loss to look at the situation. Slow-skincare readers who think of hair as skin (which it is) and want the same evidence-led framing applied to the scalp.
Not the right product if your hair loss is sudden, patchy, painful, or accompanied by systemic symptoms; that is a dermatology appointment, not a DNA test. Not for readers who already have a treating dermatologist and an active prescription. Not for women who suspect a hormonal driver beyond androgenetic patterning; in that case, pair this with a hormone test like Veracity or Hormona (also in this round).
Features that matter
- 13-gene, 48-variant panel. Broader than the 4 or 5 SNPs most direct-to-consumer hair tests cover. Includes the AR variants that genuinely correlate with male pattern severity and the SRD5A2 variants that affect DHT conversion. Not whole-genome scope, but the right scope for the question.
- Treatment-response markers. The panel estimates likely response to finasteride and minoxidil based on variant patterns. The evidence behind this is real but modest. Treat it as a hint, not a prediction.
- Free telehealth follow-up. Roughly 15 to 20 minutes with a clinician who reviews the report, asks structured questions about your hair loss, and discusses options. This is the actual deliverable.
- Compounded topical option. If you and the clinician agree, Nimbus can ship a custom topical combining finasteride, minoxidil, and adjunct agents. This is the business model and the source of most of the negative reviews. Read the cost structure carefully.
- DHT pathway focus. The panel is specifically built around androgenetic alopecia, which is the most common hair loss pattern. Other hair loss types are flagged but not deeply characterized.
My contrarian take
The genetic test is the marketing hook. The clinician appointment is the product. If you stripped Nimbus down to the 15-minute telehealth call, it would still be worth the $149. The DNA report adds structure and a few useful prediction signals, but the actual decision-making in my appointment came from family history, scalp exam via video, and timeline discussion, not from the variant report. The compound topical at the end is where the model starts to feel like a funnel. The long-term refill cost is not always foregrounded. If you do not want the topical, the test and consult still deliver value. Just go in clear-eyed about what is being sold.
Real-world test
I ordered the kit on March 28, 2026, it arrived in five days, the cheek swab took about 90 seconds (two minutes of cheek rubbing per the instructions, which feels longer than it sounds). I mailed it back the same day. Results landed in the patient portal on day 11. The PDF was roughly 30 pages and included a polygenic risk score for androgenetic alopecia, treatment-response estimates for finasteride and minoxidil, and a hair-density variant summary. My report flagged a moderate AGA risk score and a likely-good response to finasteride. The telehealth call followed on day 14, with a clinician who specialized in hair loss specifically and who spent the call asking about my pattern of loss, my mother’s and father’s hair history, my stress and sleep, and my willingness to commit to a multi-year regimen. The compound topical was offered, I declined, and the call ended without pressure. The actionable takeaway: confirmed the family-history pattern, gave me a structured 12-month plan to retest hair density, and pointed me toward a topical regimen I could source independently if I wanted to start.
How it compares
Versus SelfDecode (also in this round): SelfDecode covers hair as one slice of a broader skin and beauty report. Nimbus is hair-specific and includes the clinician visit. Versus a direct dermatology appointment: a real in-clinic dermatologist will examine your scalp under magnification, possibly biopsy, and can prescribe a tailored regimen. That is probably cheaper if you have insurance. Versus Hims or Keeps: those skip the genetics entirely and go straight to the prescription. Nimbus is positioned slightly more medically. Use it if you want the genetic context and a structured first conversation. The full at-home test kits bucket has the rest of the category. Pair with a routine log if you start a topical and want to track scalp tolerance.
FAQs
Do I have to buy the compound topical? No. The telehealth call is included regardless. The topical is an optional follow-on prescription. Many users decline it.
How accurate are the treatment-response predictions? Modestly. The evidence base for genetic prediction of finasteride and minoxidil response is real but not strong enough to drive a yes-or-no decision. Use it as a hint among hints.
Will Nimbus work for women? Yes, the panel covers female pattern hair loss. The clinician follow-up is also available. The compound topical is formulated differently for female users (typically minoxidil-dominant with adjunct agents).
What if my hair loss is not genetic? The report will likely show a low AGA score and the clinician should flag other possibilities (telogen effluvium, alopecia areata, scarring alopecias) and refer you to in-person dermatology. If your clinician does not do that, get a second opinion.
Is my DNA data safe? Nimbus operates under HIPAA and offers data deletion on request. Read the privacy policy for specifics on third-party sharing and research participation.
If Nimbus confirmed an early androgenetic pattern, the practical next step is a 12-month tracking plan with monthly scalp photos and a routine that does not stress the hair follicle further. The Elelaf testing methodology covers how we read these reports without panic-starting a five-product regimen. The Elelaf editorial pillars are the rest of the frame.